Drug Utilization Review: A Description of Use for a Medicaid Population (Maryland) 1986–1994

1994 ◽  
Vol 22 (3) ◽  
pp. 247-251 ◽  
Author(s):  
Richard D. Baylis

A relatively healthy forty-six-year-old woman with mild hypertension receives a prescription for an antihypertensive medication. One of the medication's adverse effects is its potential to cause severe depression. Four months later, she is diagnosed with anxiety, an early manifestation of depression. An antianxiety drug is prescribed, but her anxiety worsens. Her physician then diagnoses her as having a depressive disorder, and prescribes a new antidepressant medication. She is still on the same antihypertensive.A seventy-two-year-old man is given furosemide and digoxin to control a mild case of congestive heart failure and hypertension. Because furosemide deletes potassium from the body, his physician also places him on a potassium supplement. Six months later, the physician tells the patient to stop taking the furosemide and prescribes an angiotensin converting enzyme (ACE) inhibitor. An effect of ACE inhibitors is to reduce the body's excretion of potassium thereby reducing the digoxin's effectiveness.

2019 ◽  
Vol 41 (3) ◽  
pp. 356-363 ◽  
Author(s):  
Angélica Godoy Torres Lima ◽  
Clécia Cristiane da Silva Sales ◽  
Welton Flávio de Lima Serafim

ABSTRACT Introduction: Chronic kidney disease (CKD) is rare in children, but it causes repercussions in several aspects of life, because the disease and treatment cause great changes in the daily lives of the child and his family, increasing the burden on caregivers. Objective: To evaluate the burden of primary caregivers of children and adolescents who undergo renal replacement therapy (RRT). Methods: Cross-sectional, observational study performed at the Pediatric Renal Unit of a school hospital in the Northeast. Forty-nine primary caregivers of pediatric patients with CKD in RRT followed up in our clinic participated in the study. We used validated instruments to assess burden, depression and anxiety. We ran some tests to analyze the findings of burden, depression and anxiety in the sample. Results: Most of the caregivers are the mothers of these children (89.8%), aged between 36 and 45 years (46.9%), have Elementary School education only (55.1%) and reported feeling pain in the body (69.4%), but they did not have chronic disease. The majority of the children have been in RRT from 1 to 3 years (40.8%), aged from 9 to 11 years (30.6%), are male (55.1%), and under hemodialysis (38.8%). The caregivers had a moderate level of burden (2.10), a high prevalence of moderate to severe depression (18.4%) and anxiety (47%), and a strong correlation between burden, depression and anxiety. Conclusions: Caring for a child with CKD is an intense experience, with negative consequences, due to uncertainties about the future and the very care these children require. We need to do something to help these caregivers better manage care, as well as cope with their own feelings.


CNS Spectrums ◽  
2008 ◽  
Vol 13 (S11) ◽  
pp. 15-21 ◽  
Author(s):  
Michael T. Isaac

AbstractThere is evidence that the serotonin norepinephrine reuptake inhibitors (SNRIs) venlafaxine, milnacipran, and duloxetine, have probable superior antidepressant activity to most selective serotonin reuptake inhibitors (SSRIs), especially in more severe depression. Some patients, however, respond better than others to SNRIs. Several factors influencing response to milnacipran have been recently studied. The presence of certain polymorphisms related to noradrenergic neurotransmission has been shown to be related to different degrees or rapidity of response to milnacipran. In addition, patients with low pretreatment levels of plasma 3-methoxy-4-hydroxyphenylglycol have a better response to milnacipran. These recent genomic and neurochemical data confirm that milnacipran, in contrast to SSRIs and venlafaxine, has an impact on the noradrenergic system. Differences in metabolism determined by genetic variables in cytochrome P450 (CYP) 2D6 activity are a major determinant of venlafaxine levels to such an extent that genetically determined decreases in CYP 2D6 activity have been associated increased adverse effects. Milnacipran, which is not metabolized by the enzymes of the CYP system is not influenced by polymorphism of these enzymes. These preliminary data suggest that a patient's biochemical and pharmacogenetic characteristics may be useful in the future to help clinicians chose the most  effective antidepressant medication.


2014 ◽  
Vol 22 (5) ◽  
pp. 866-873 ◽  
Author(s):  
Bianca Fresche de Souza ◽  
Jéssica Andrade de Moraes ◽  
Aline Inocenti ◽  
Manoel Antônio dos Santos ◽  
Ana Elisa Bauer de Camargo Silva ◽  
...  

Objective to verify depressive symptoms and adherence to chemotherapy among women with breast cancer who are served by the Pharmacy of the Chemotherapy Center of a university hospital.METHOD: cross-sectional study with quantitative approach conducted with 112 women receiving chemotherapy. Structured interviews guided by a script addressing socio-demographic, clinical and therapeutic information, the Morisky Test, and the Beck Depression Inventory were used to collect data.RESULTS: 12.50% and 1.78% of the patients experienced "moderate" and "severe" depression, respectively, while 10.59% did not use antidepressant medication. A statistically significant association was found between levels of depression and the use of antidepressants. Lack of adherence was identified in 46.43% of the participants.CONCLUSION: these findings show the need to regularly screen for depressive symptoms and for adherence to chemotherapy treatment among women with breast cancer, in order to provide early detection and appropriate treatment centered on patients, and to improve their quality of life.


Author(s):  
Sudhir R. Kaulage ◽  
Kiran T. Aldar ◽  
Rahul P. Jadhav ◽  
Prakash D. Jadhav ◽  
Vishal D. Yadhav

Depression is a life-threatening, debilitating, and common disease affecting different segments of community. Chemical and synthetic drugs available to treat this disease cause many adverse effects and may lead to complete recovery in only 50% of patients. Antidepressants are effective and accessible treatment options that can reduce suffering and prevent relapse of symptoms. They are recommended as first line treatment options in moderate and severe depression or mild or sub threshold depression that has persisted despite other interventions All current antidepressants, with the exception of agomelatine, increase the transmission of the monoamines, particularly serotonin, nor adrenaline and dopamine. The antidepressants are crucial for the treatment of depressive episodes in the acute phase when untreated symptoms are at their worst. With long-term use, however, the brain sets to work compensating for the drug-induced changes with a process he calls oppositional tolerance. Antidepressant drugs are the mainstay for the treatment of depression. Usually, antidepressants are given in combination with some form of limited supportive psychotherapy.


2019 ◽  
Vol 27 (4) ◽  
pp. 418-428
Author(s):  
Sandra Ramos ◽  
Jorge A. Ramos

Aims: To analyze the process of change and the effectiveness of five sessions of family constellations (FC) using mixed methods in mixed settings (videoconference and in person). To obtain variables associated with processes and results. Methods: Using an exploratory design with mixed methods, this single case study used a triangulation of data: quantitative ( Escala de Ansiedade, Depressão e Stresse-21) and qualitative (the notes from the consultations and the patient’s responses to the Psychotherapeutic Process Data Mining Questionnaire [PPDMQ]). Results: The patient’s symptoms of depression went from a level of severe to normal, and the posttest results persisted after a 3-month follow-up. The severe depression seems to have been mitigated through interventions that promoted contact with reality, self-determination, the psychoemotional establishment of systemic places, and through finding meaning in autobiographical events. Conclusions: This article may encourage further studies that use the PPDMQ to create a metasynthesis and to gauge whether the effectiveness of FC, as a systemic, intergenerational, and integrative psychotherapy, could plausibly contribute to enrich the body of scientific evidence–based psychotherapies and mitigate the global escalation of depression.


2017 ◽  
Vol 41 (S1) ◽  
pp. S746-S746
Author(s):  
A. Samico ◽  
J. Perestrelo ◽  
Â. Venâncio

IntroductionCotard syndrome (CS) is a rare neuropsychiatric condition characterized by nihilistic delusions, which may range from negation of existence of parts of the body to delusion of being dead or negation of self-existence, and it requires an urgent and appropriate therapy.ObjectivesOur objective is to highlight the importance of CS, reinforcing that medical professionals should be aware of this pathology to prompt clinical description, diagnostic and treatment.AimsThe aim of this presentation is to alert psychiatrists to this remaining syndrome.MethodsReview of phenomenological and theoretical issues regarding SC.ResultsCS can be found in numerous psychiatric or neurologic pathologies but it is most seen in patients with severe depression. It is typically divided in three subtypes: psychotic depression, Cotard type I, with nihilistic delusions without mood symptoms, and Cotard type II, with mood symptoms and auditory hallucinations. There are numerous etiological hypothesis mechanisms, including unusual perceptual experiences, which can similarly be involved in Capgras delusion, disconnection from emotional or limbic processes, an impaired belief evaluation or a tendency to excessive self-attribution. Frontotemporoparietal circuitry also seems to have an important role in its pathology. Treatment usually involves electroconvulsive therapy, antidepressants and anti-psychotics and the prognosis depends on the underlying disorders.ConclusionsCS is a rare pathology with self-defeating risk and its clinical recognition and proper treatment are essential to improve the prognosis of these patients. Diagnostic criteria or clinical instruments for assessment of this syndrome should be encouraged, since its lack is a limitation for systematic studies and consequent management advances.Disclosure of interestThe authors have not supplied their declaration of competing interest.


Author(s):  
Khadijah Irandoust ◽  
Morteza Taheri ◽  
Hamdi Chtourou ◽  
Pantelis Theo Nikolaidis ◽  
Thomas Rosemann ◽  
...  

Since the prevalence of depression is high among athletes at the end of their athletic career, the purpose of this study was to investigate the effect of time-of-day-exercise in group settings on the level of the mood and depression of former elite male athletes.Out of 187 volunteers referring to the sports counseling clinic, 71 retired male athletes who had a national championship record were randomly divided into two morning and evening exercise groups. The inclusion criteria were severe depression (high score in the Beck Depression Inventory-II), the age range of 50 to 60 years, the absence of metabolic syndrome, and the body mass index (BMI) between 28 and 35. All body composition variables were measured using body composition analysis (In Body 320; Korea). The second stage was the collection of data after three months (completion of the training protocol). After data collection, independent and dependent t-tests were used to analyze the data. The results indicated that both groups had a significant improvement in depression compared to the pre-test (p ≤ 0.05), while there was no significant difference between the two groups (p ≥ 0.05). The overall conclusion is that exercise at different times of the morning or evening can improve the psychological state and reduce depression.


2020 ◽  
Vol 34 (5) ◽  
pp. 443-453 ◽  
Author(s):  
Olusola Ayandele ◽  
Olugbenga A Popoola ◽  
Tolulope O Oladiji

PurposeThis study examined the prevalence and relationship between addictive use of smartphones and symptoms of depression and anxiety among female undergraduates.Design/methodology/approachStandardized scales were used to measure the addictive use of smartphones, depression and anxiety among 398 female students (mean age 21.75 years, SD = 2.67) at two large higher institutions in southwest Nigeria and were opportunely sampled. Two hypotheses were tested using Spearman's rho and Mann–Whitney U tests.FindingsThe results showed that 1.01% of the respondents were probable smartphone addicts and 17.34% were at-risk, while 14.32% and 16.33% manifested symptoms of anxiety and moderate-to-severe depression, respectively. Depression (r = 0.24, p < 0.01) and anxiety (r = 0.21, p < 0.01) have significant relationship with addictive use of smartphone. Addictive/at-risk smartphone users significantly scored higher on symptoms of depression (average rank of 233.40) than normal smartphone users (average rank of 191.88); U = 9387.50; z = −2.81, p < 0.05; Also, addictive/at-risk smartphone users reported significantly higher level of anxiety (average rank of 229.27) than normal smartphone users (average rank of 192.81); U = 9689.00; z = −2.46, p < 0.05.Research limitations/implicationsGeneralizing these results to a clinical setting and other at-risk demographic groups might prove difficult due to the respondents' condition of homogeneity.Practical implicationsThe findings suggest that relationships exist between the addictive use of smartphones and symptoms of depression and anxiety among undergraduate students in southwest Nigeria. Clinicians should assess smartphone use in the management of depression and anxiety disorders.Social implicationsUniversity administrators should target prevention and intervention strategies that would assist students to be taught positive ways of using their smartphones.Originality/valueThe study contributes to the body of knowledge by revealing relationships between smartphone addiction and mental health in an African sample.


1966 ◽  
Vol 112 (484) ◽  
pp. 269-276 ◽  
Author(s):  
David Murray Shaw ◽  
Alec Coppen

The ionic theory of cell excitability shows how impulses are generated, conducted and propagated by movements of ions between the cells and the extracellular fluid. It is known that changes in the concentration of sodium and potassium in either the extracellular water (E.C.W.) or the intracellular water (I.C.W.) may have a marked effect on the resting and action potentials of excitable cells. If affective disorders are manifestations of complex but reversible changes in brain excitability, hen these in turn might be caused by alterations in the concentration of electrolytes within the cells of the central nervous system (C.N.S.). Although it is not possible to measure the distribution of electrolytes specifically in the C.N.S. in man, it is possible to measure their distribution in the body as a whole. In previous papers we have shown that residual sodium (intracellular plus a small quantity of bone sodium) is increased by 50 per cent. in depression (Coppen and Shaw, 1963) and by nearly 200 per cent. in mania (Coppen, Shaw, Malleson and Costain, 1965). The present paper shows that there are also abnormalities in the distribution of potassium, the other main cation determining cell excitability, in patients suffering from severe depression.


2022 ◽  
Vol 6 ◽  
Author(s):  
Ni Ketut Sri Diniari

Detection of mental disorders in the elderly are using the Abbreviated Mental Test (AMT) screening/questionnaire, Depression Anxiety Stress Scale (DASS), Geriatric Depression Scale (GDS), Pittsburgh Sleep Quality Index (PSQI) and Visual Analog Scale (VAS) and/or or based on structured interviews. The elderly who had complete screening and interview data were included in the study sample, i.e., 85 people. From 85 elderly as a participant, 65 people (76.4%) had a good cognitive, 10 (11.7%) moderate cognitive, and 5 severe cognitive (5.8%), but their daily activities were still good. The results of the screening GDS showed 70 people with mild depression (82.4%), moderate depression in 13 people (15.3%) and 2 people with severe depression (2.3%). The results of the screening with DASS show 15 elderly people with depression (17.5%), 55 people with anxiety (65%) and 15 people experiencing stress (17.5%). Screening for elderly sleep quality with the PSQI for elderly showed 60 people with disrupted sleep quality (70.5%) and 15 people with good sleep quality (17.6%). A 68 people elderly (80%) complained of mild pain and 17 people (20%) with moderate pain by screening using the VAS, where the location of the pain varied in the body and leg areas.


Sign in / Sign up

Export Citation Format

Share Document